BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24373225)

  • 41. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases.
    Lewandrowski KU; Nanson C; Calderon R
    Spine J; 2007; 7(5):609-14. PubMed ID: 17526434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion.
    Aichmair A; Girardi FP; Hughes AP; Sama AA; Lebl DR; Cammisa FP
    Spine J; 2013 Oct; 13(10):1411-2. PubMed ID: 24139750
    [No Abstract]   [Full Text] [Related]  

  • 47. A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Wetzell B; McLean JB; Dorsch K; Moore MA
    J Orthop Surg Res; 2021 Nov; 16(1):680. PubMed ID: 34794470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years.
    Singh K; Smucker JD; Gill S; Boden SD
    J Spinal Disord Tech; 2006 Aug; 19(6):416-23. PubMed ID: 16891977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2.
    Pimenta L; Marchi L; Oliveira L; Coutinho E; Amaral R
    J Neurol Surg A Cent Eur Neurosurg; 2013 Nov; 74(6):343-50. PubMed ID: 23444134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ; Nowitzke AM; Wood MJ
    Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) in real world spine surgery. A phase IV, National, multicentre, retrospective study collecting data from patient medical files in French spinal centres.
    Vincentelli AF; Szadkowski M; Vardon D; Litrico S; Fuentès S; Steib JP; Le Huec JC; Huppert J; Dubois G; Lenoir T; Sailhan F; Passuti N
    Orthop Traumatol Surg Res; 2019 Oct; 105(6):1157-1163. PubMed ID: 31324520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes.
    Kleeman TJ; Ahn UM; Talbot-Kleeman A
    Spine (Phila Pa 1976); 2001 Dec; 26(24):2751-6. PubMed ID: 11740368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review.
    Mindea SA; Shih P; Song JK
    Spine (Phila Pa 1976); 2009 Jun; 34(14):1480-4; discussion 1485. PubMed ID: 19525840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
    Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
    Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
    J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood serum antibody analysis and long-term follow-up of patients treated with recombinant human bone morphogenetic protein-2 in the lumbar spine.
    Burkus JK; Gornet MF; Glassman SD; Slosar PJ; Rosner MK; Deckey JE; Nowak J; Hatcher BM
    Spine (Phila Pa 1976); 2011 Dec; 36(25):2158-67. PubMed ID: 21325990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis.
    Lindley TE; Dahdaleh NS; Menezes AH; Abode-Iyamah KO
    J Neurosurg Pediatr; 2011 May; 7(5):468-74. PubMed ID: 21529186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2.
    Knox JB; Dai JM; Orchowski J
    Spine (Phila Pa 1976); 2011 Apr; 36(8):672-6. PubMed ID: 21217443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ectopic bone formation with joint impingement after posterior lumbar fusion with rhBMP-2.
    Bannwarth M; Kleiber JC; Marlier B; Eap C; Duntze J; Litre CF
    Orthop Traumatol Surg Res; 2016 Apr; 102(2):255-6. PubMed ID: 26947733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.